NCT06469307

Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Dana-Farber Cancer Institute · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this research study is to enhance inclusion and diversity in clinical trial enrollment by training participants to perform and provide feedback through a community-based protocol review process, called DIVERSE.

Detailed description

This research study aims to pilot a protocol review process, called DIVERSE, assessing its feasibility, acceptability, and preliminary efficacy to enhance inclusion and diversity in clinical trial enrollment. Patients and community participants will complete specialized training and provide feedback on clinical trials in development through the DIVERSE process; they will also provide feedback on the process itself. Investigator participants will request review and provide feedback on the DIVERSE process. The study is based on community-based participatory research. Participation in this research is expected to last about 18 months. It is expected that about 20 patient and community participants and 20 investigators will participate in this research study. The National Cancer Institute and American Society of Clinical Oncology are providing funding for this research study.

Conditions

• Blood Cancer
• Leukemia

Interventions

Type	Name	Description
OTHER	DIVERSE Review Process	A participant and community-based review system for clinical research protocols that elicits and collects feedback on investigator-initiated protocol reviews.

Timeline

• Start date: 2024-12-09
• Primary completion: 2026-07-01
• Completion: 2027-06-30
• First posted: 2024-06-21
• Last updated: 2025-06-03

Locations

1 site across 1 country: United States